Piper Alderman

Our lawyers are regularly asked to share their knowledge of current legal and industry issues and the impact of legislative changes at conferences, seminars and other events run by industry bodies, government organisations and educational institutions around Australia and internationally. 

Piper Alderman's lawyers are speaking at the following upcoming events:

 


10th Annual Insolvency Practice Symposium

Brisbane, Melbourne and Sydney

Key Topics:

  • Analyse the practical implications of recent case law such as Octaviar and Timbercorp and understand how to apply the lessons to your practice
  • Asses recent uses of DOCAs, creditors' trusts, rights & protections for creditors and key issues to consider when setting up arrangement
  • Understand proposed changes to the Bankruptcy Act, the reform agenda and how these amendments will impact your business
  • Understand director duties and practitioner liabilities under s79 of the Corporations Act and take steps to minimise risks across your organisation
  • Discuss recent cases regarding practitioner remuneration and circumstances where equitable lien may apply for payment of remuneration

Dates:

             Brisbane       18th -19th February, 2010 - Brisbane Marriott

             Sydney          22nd - 23rd February, 2010 - The Grace Hotel

             Melbourne    25th - 26th February, 2010 - The Stamford Plaza

Piper Alderman representatives:

Paul Evans, Partner, will be speaking in Brisbane on the topic Garnishee notices and tax-related liabilities and;

Michael Lhuede, Partner, will be speaking in Sydney and Melbourne on the topic Garnishee notices and tax-related liabilities.

For further information including registration details, please click on the following link www.qldbar.asn.au/eventtest/event_mp3s/1951852606_TC100218.pdf

 


Commercialisation of Biomakers: From Discovery to Medical Diagnostics

Breakout Sessions
 
: 5th March 2010 4:00 PM - 5:30 PM 
 
: McCormick Place, Chicago
 
Description:
 
Medical research is evolving toward identifying biological variations that determine individual disease susceptibility, prognosis and treatment outcomes. The dramatic increase in discovery of biomarkers, as measured by biomarker-related patent filings and publications, continues to outpace their clinical validation and market introduction. Clinical validation of biomarkers is a resource-intensive process involving assay development, validation of analytical methods, development of protocols for tissue acquisition, storage and processing, and retrospective and prospective clinical studies to determine sensitivity and specificity. To make the substantial investment required to bring a novel biomarker to market, test developers require that candidate markers to meet a range of technical, clinical, regulatory and commercial criteria.
 
Piper Alderman Representatives:
 
Tim Clark, a Partner at Piper Alderman will be Chairing the session.
 
For further information on this event, please click on the following link
 
bio2010.bdmetrics.com/SOW-29100340/Commercialization-of-Biomarkers-From-Discovery-to-Medical-Diagnostics/Overview.aspx

Credit Law Compliance Summit

Tonkin Corporation

Summary:

The Credit Law Compliance Summit will help you update your compliance training programs and amend documents and procedures to ensure compliance across your business.

Event Details:

21st - 23rd of April 2010

The Grace Hotel, Sydney

Piper Alderman Representatives:

Mark Poczman, Partner, Piper Alderman will be talking on Day Two, Thursday April 22nd at 2:15PM on the topic 'The New Rules for Credit Providers Under the Personal Property Securities Bill'.

For further information and for registration details please click on the following link

www.tonkincorporation.com/